Buhl, A;Page, S;Heegaard, NH;von Landenberg, P;Luppa, PB
Optical biosensor-based characterization of anti-double-stranded DNA monoclonal antibodies as possible new standards for laboratory tests.
Biosens Bioelectron
2009
25
1
198-203

Metzger, J;Luppa, PB;Good, DM;Mischak, H
Adapting mass spectrometry-based platforms for clinical proteomics applications: The capillary electrophoresis coupled mass spectrometry paradigm.
Crit Rev Clin Lab Sci
2009
46
3
129-52

Novotny, AR;Luppa, P;Rosenberg, R;Schneider, H;Maak, M;Bartels, H;Holzmann, B;Friess, H
Procalcitonin can be used for monitoring sepsis in patients with medullary thyroid carcinoma.
Thyroid
2009
19
11
1287-9

Spiessberger, B;Bernhard, D;Herrmann, S;Feil, S;Werner, C;Luppa, PB;Hofmann, F
cGMP-dependent protein kinase II and aldosterone secretion.
FEBS J
2009
276
4
1007-13

Mooney, MH;Bergwerff, AA;van Meeuwen, JA;Luppa, PB;Elliott, CT
Biosensor-based detection of reduced sex hormone-binding globulin binding capacities in response to growth-promoter administrations.
Anal Chim Acta
2009
637
1-2
235-40

Laika, B;Leucht, S;Heres, S;Steimer, W
Intermediate metabolizer: increased side effects in psychoactive drug therapy. The key to cost-effectiveness of pretreatment CYP2D6 screening?
Pharmacogenomics J
2009
9
6
395-403

Nguyen, DL;Staeker, J;Laika, B;Steimer, W
TaqMan real-time PCR quantification strategy of CYP2D6 gene copy number for the LightCycler 2.0.
Clin Chim Acta
2009
403
1-2
207-11

Thaler, M;Buhl, A;Welter, H;Schreiegg, A;Kehrel, M;Alber, B;Metzger, J;Luppa, PB
Biosensor analyses of serum autoantibodies: application to antiphospholipid syndrome and systemic lupus erythematosus.
Anal Bioanal Chem
2009
393
5
1417-29

Popp, J;Leucht, S;Heres, S;Steimer, W
DRD4 48 bp VNTR but not 5-HT 2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain.
Pharmacogenomics J
2009
9
1
71-7